Dino A Rossi, a director at Krystal Biotech, Inc. ($KRYS), reported $8.23 million in same-day stock sales on August 14, 2026. The eight transactions covered 25,000 shares. The largest block was a 7,428-share sale at $329.60 per share, totaling $2,448,279.94. After that transaction, Rossi held 58,031 shares. The Form 4 filing landed on the trade date itself.
The other August 14 sales ranged in size and price. Rossi sold 5,226 shares at $327.39 for $1,710,960.52, 4,896 shares at $330.36 for $1,617,422.00, and 3,095 shares at $331.43 for $1,025,786.06. He also sold 2,287 shares at $326.60 for $746,940.60, 1,687 shares at $328.52 for $554,205.14, and 341 shares at $325.60 for $111,029.09. The smallest transaction was 40 shares at $333.23, worth $13,329.20. Per-share prices across the eight rows ran from $325.60 to $333.23.
Rossi's $KRYS Form 4 history includes earlier 2026 activity. On February 19, he reported two sales: 10,834 shares at $262.10 per share for $2,839,591.40 and 8,116 shares at $260.49 per share for $2,114,102.75. Together, those 18,950 shares brought roughly $4.95 million. That filing reached the SEC on February 23, four days after the trade date.
Other Krystal Biotech insiders sold earlier in the year. On March 4, CEO Krish Krishnan and President Suma Krishnan each reported 10 sale transactions. The two reported totals were 25,000 shares apiece, or 50,000 shares combined, with an aggregate value of roughly $13.16 million. Krish Krishnan's ten transactions totaled about $6.58 million. Suma Krishnan's ten transactions totaled about $6.58 million. Those trades were filed on March 6, two days after trading.
Across the two selling dates Rossi reported in the database, his $KRYS sales totaled 43,950 shares and roughly $13.18 million. The February filing listed shares-owned-after figures of 89,525 and 78,691 for its two transactions. The August 14 rows listed post-sale holdings ranging from 50,000 to 74,659 shares.
Krystal Biotech operates in the biotechnology sector and has a market capitalization of roughly $9.55 billion. The congressional STOCK Act database contains one $KRYS filing: a purchase reported by Representative Christopher L. Jacobs, a Republican member of the House. The trade date was December 12, 2022, and the disclosure followed on January 20, 2023, 39 days after the trade.
Disclosure timing varied across the 2026 $KRYS clusters. The February 19 sales reached the SEC on February 23. The March 4 sales reached the SEC on March 6. The August 14 sales reached the SEC on the transaction date itself.